Back to search results

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

B-Cell Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Anhui Provincial Children's Hospital, Hefei, Anhui, China

    Contact: Study coordinator (Hongjun Liu, MD) · 13515657759@126.com · 13515657759

  • Fujian Children's Hospital, Fuzhou, Fujian, China

    Contact: Study coordinator (Hui Zhang, PhD/MD) · zhanghui@scmc.com.cn · 15821333007

  • Shanghai Children's Medical center, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Shuhong Shen, PhD/MD) · shenshuhong@scmc.com.cn · 86-21-38626161
    Contact: Study coordinator (Wenting Hu, MD) · huwenting@scmc.com.cn · 13524836748
    Contact: Principal Investigator (Shuhong Shen, PhD/MD)
    Wenting Hu, MD (Sub-investigator)
    Changcheng Chen, MD (Sub-investigator)

  • Ningbo Women and Children's Hospital, Ningbo, Zhejiang, China

    Contact: Study coordinator (Binfei Hu, MD) · hbfdkc@sina.com · 13777028360
View source on ClinicalTrials.gov(opens in a new tab)